Monopar Therapeutics (MNPR) Q4 2024 Annual Earnings
MNPR·Reported March 31, 2025·Before market open
Diluted EPS came in at $-2.23, missed the $-0.36 consensus by $1.87.
Diluted EPS
$-2.23missed by $1.87
Consensus: $-0.36
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Monopar Therapeutics's Q4 2024 earnings report.
Monopar Therapeutics (MNPR) reported Q4 2024 earnings on March 31, 2025 before market open.
Monopar Therapeutics reported diluted EPS of $-2.23 for Q4 2024.
EPS missed the consensus estimate of $-0.36 by $1.87.
You can read the 10-K periodic report (0001437749-25-009979) directly on SEC EDGAR. The filing index links above go to sec.gov.